Published in AIDS Weekly, January 30th, 2006
Scientists writing in the journal Sexually Transmitted Diseases reported, "This phase I dose-ranging study of 2 weeks of twice-daily dextrin sulphate (DS), a sulphated polymer with in vitro activity against HIV, was designed in 2 parts. Part A was a randomized, placebo-controlled, double-blind, 3-arm trial (DS4%, DS1%, placebo) in HIV-negative women."
"In part B," described S. McCormack and colleagues, "HIV-positive women received DS4% and HIV-negative women were randomized to DS4% or no gel. One hundred women were enrolled from 2 sites (London and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.